The trademark application ADVZ was filed by MERCURY PHARMA GROUP LIMITED, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on April 21, 2022, and it was registered by office on July 29, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).